Liu et al., 2021 - Google Patents
Advances in 3D bioprinting technology for cardiac tissue engineering and regenerationLiu et al., 2021
View HTML- Document ID
- 3954356519048595004
- Author
- Liu N
- Ye X
- Yao B
- Zhao M
- Wu P
- Liu G
- Zhuang D
- Jiang H
- Chen X
- He Y
- Huang S
- Zhu P
- Publication year
- Publication venue
- Bioactive Materials
External Links
Snippet
Cardiovascular disease is still one of the leading causes of death in the world, and heart transplantation is the current major treatment for end-stage cardiovascular diseases. However, because of the shortage of heart donors, new sources of cardiac regenerative …
- 230000000747 cardiac effect 0 title abstract description 110
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION, OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
- A61L27/3804—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by specific cells or progenitors thereof, e.g. fibroblasts, connective tissue cells, kidney cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION, OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
- A61L27/3839—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by the site of application in the body
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Liu et al. | Advances in 3D bioprinting technology for cardiac tissue engineering and regeneration | |
Ren et al. | Developments and opportunities for 3D bioprinted organoids | |
Tan et al. | Applications of 3D bioprinting in tissue engineering: advantages, deficiencies, improvements, and future perspectives | |
Alonzo et al. | 3D Bioprinting of cardiac tissue and cardiac stem cell therapy | |
Qasim et al. | 3D printing approaches for cardiac tissue engineering and role of immune modulation in tissue regeneration | |
Cui et al. | 3D bioprinting for cardiovascular regeneration and pharmacology | |
Cho et al. | Reconstructing the heart using iPSCs: Engineering strategies and applications | |
Zhang et al. | 3D bioprinting: a novel avenue for manufacturing tissues and organs | |
Takahashi et al. | Thermally-triggered fabrication of cell sheets for tissue engineering and regenerative medicine | |
Vunjak-Novakovic et al. | Challenges in cardiac tissue engineering | |
Ong et al. | 3D and 4D bioprinting of the myocardium: current approaches, challenges, and future prospects | |
Moldovan et al. | Principles of the Kenzan method for robotic cell spheroid-based three-dimensional bioprinting | |
Zhang et al. | 3D bioprinting for tissue and organ fabrication | |
Hasan et al. | Microfluidic techniques for development of 3D vascularized tissue | |
Lund et al. | The natural and engineered 3D microenvironment as a regulatory cue during stem cell fate determination | |
Lovett et al. | Vascularization strategies for tissue engineering | |
Serpooshan et al. | Bioengineering cardiac constructs using 3D printing | |
Zhao et al. | The role of tissue engineering and biomaterials in cardiac regenerative medicine | |
Agarwal et al. | Recent advances in bioprinting technologies for engineering cardiac tissue | |
Betancourt et al. | Review of extrusion-based multi-material bioprinting processes | |
Tomov et al. | Engineering functional cardiac tissues for regenerative medicine applications | |
Portillo-Lara et al. | Biomimetic cardiovascular platforms for in vitro disease modeling and therapeutic validation | |
Jo et al. | Bioprinting-assisted tissue assembly to generate organ substitutes at scale | |
US9328327B2 (en) | Method for producing an organ replica, in particular a functional model | |
Mousavi et al. | Tissue-engineered heart chambers as a platform technology for drug discovery and disease modeling |